Stephan Kontos
Direttore/Membro del Consiglio presso Aperiam Bio, Inc.
Posizioni attive di Stephan Kontos
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Aperiam Bio, Inc.
 Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Direttore/Membro del Consiglio | 01/03/2022 | - |
Storia della carriera di Stephan Kontos
Precedenti posizioni note di Stephan Kontos
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investitore di Private Equity | 01/10/2022 | 01/05/2024 |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Direttore Tecnico/Scientifico/R&S | 31/12/2012 | 01/10/2022 |
| Fondatore | - | 01/10/2022 | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Fondatore | 01/01/2015 | - |
Formazione di Stephan Kontos
| The University of Texas at Austin | Undergraduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Svizzera | 3 |
Posizioni
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Aperiam Bio, Inc.
Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Health Technology |
- Borsa valori
- Insiders
- Stephan Kontos
- Esperienza
